{"id":10610,"date":"2011-08-04T08:47:11","date_gmt":"2011-08-04T12:47:11","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?post_type=news&#038;p=10610"},"modified":"2011-08-04T08:47:53","modified_gmt":"2011-08-04T12:47:53","slug":"pfizer-wants-to-market-otc-atorvastatin-lipitor","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2011\/08\/04\/pfizer-wants-to-market-otc-atorvastatin-lipitor\/","title":{"rendered":"Pfizer Wants to Market OTC Atorvastatin (Lipitor)"},"content":{"rendered":"<p>Pfizer will attempt to gain FDA approval to sell atorvastatin (Lipitor) over-the-counter, according to <a href=\"http:\/\/online.wsj.com\/article\/SB10001424053111903885604576486393490294726.html?mod=WSJ_hp_LEFTTopStories\">a report by Peter Loftus in the <em>Wall Street Journal.<\/em><\/a> In the past, the FDA has turned down requests to market other statins over-the-counter. Lipitor is scheduled to go off patent in November, well before an OTC version of the drug could become available.<\/p>\n<p>Many believe Pfizer faces a long upward climb with no assurance of success. But Loftus quotes an FDA spokesperson who states that &#8220;the agency is open to discussing OTC statins, as long as companies are ready to demonstrate that consumers will make the right decisions.&#8221;<\/p>\n<p>The chair of an FDA advisory panel in 2008 that rejected OTC lovastatin explained that panel&#8217;s reasoning in <a href=\"http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMsb0801202\">an article in the <em>New England Journal of Medicine<\/em>.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer will attempt to gain FDA approval to sell atorvastatin (Lipitor) over-the-counter, according to a report by Peter Loftus in the Wall Street Journal. In the past, the FDA has turned down requests to market other statins over-the-counter. Lipitor is scheduled to go off patent in November, well before an OTC version of the drug [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,7],"tags":[585,934,935,584],"class_list":["post-10610","post","type-post","status-publish","format-standard","hentry","category-general","category-prevention","tag-atorvastatin","tag-lipitor","tag-over-the-counter","tag-statins"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/10610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=10610"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/10610\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=10610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=10610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=10610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}